Telerehabilitation dual-task training for improving balance and gait in Parkinson's patients
Multidimensional Evaluation of the Effectiveness of Telerehabilitation-Based Dual-Task Training in Parkinson's Patients
This study tests if a new online exercise program that combines thinking and movement can help improve balance and walking in people with Parkinson's Disease.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 30 Years to 75 Years |
| Sex | All |
| Sponsor | Fenerbahce University Academic / other |
| Locations | 1 site (Istanbul, Bakırköy) |
| Trial ID | NCT06416722 on ClinicalTrials.gov |
What this trial studies
This clinical study evaluates the effectiveness of telerehabilitation-based dual-task training to enhance balance and gait function in individuals with Parkinson's Disease. Participants will be randomly assigned to three groups, each receiving different dual-task exercise programs that combine cognitive and motor activities. The study aims to determine the optimal content of these programs for maximum rehabilitation benefits. By leveraging telerehabilitation, the study seeks to provide accessible exercise options for patients managing their symptoms remotely.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with idiopathic Parkinson's Disease, stages 1-3 on the Hoehn-Yahr scale, who can walk independently and have stable medication.
Not a fit: Patients with serious hearing or vision problems, other neurological disorders, or those lacking internet access may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve balance and gait function in patients with Parkinson's Disease, enhancing their quality of life.
How similar studies have performed: While dual-task training has shown effectiveness in Parkinson's rehabilitation, the specific approach of telerehabilitation for this purpose is relatively novel and underexplored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with idiopathic Parkinson's Disease * Stage 1-3 on the Hoehn-Yahr scale * A minimum score of 21 on the Montreal Cognitive Assessment Scale test * Stable drug treatment within the last 1 month * Patients are in the "On" period * Ability to walk independently on level ground (3 and above according to Functional Ambulation Classification) Exclusion Criteria: * Serious hearing or vision problems * Having other neurological, cardiovascular or orthopaedic disorders that may prevent walking * Any other neurological disorder (e.g. dementia, cerebrovascular disease) * less than 5 years of education * To have vascular lower extremity pathologies * Not having internet access via smartphone or computer
Where this trial is running
Istanbul, Bakırköy
- Bakırköy Prof. Dr. Mazhar Osman Ruh Sağlığı ve Sinir Hastalıkları Eğitim ve Araştırma Hastanesi — Istanbul, Bakırköy, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Ezgi Gul, MSc, Pt, Research Assistant
- Email: fzt.ezgigul@gmail.com
- Phone: 05071180878
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.